KEGG   DRUG: Pneumococcal 20-valent conjugate vaccine
Entry
D12207                      Drug                                   

Name
Pneumococcal 20-valent conjugate vaccine;
Prevnar 20 (TN)
Product
Class
Other
 DG01686  Inactivated vaccine
Remark
ATC code: J07AL02
Product: D12207<US>
Efficacy
Active immunization (pneumococcal)
  Disease
Prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F [DS:H01321]
Comment
Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07A BACTERIAL VACCINES
    J07AL Pneumococcal vaccines
     J07AL02 Pneumococcus, purified polysaccharides antigen conjugated
      D12207  Pneumococcal 20-valent conjugate vaccine <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D12207
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12207
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system